BFD-22 a new potential inhibitor of BRAF inhibits the metastasis of B16F10 melanoma cells and simultaneously increased the tumor immunogenicity.
Ferreira AK, Pasqualoto KF, Kruyt FA, Palace-Berl F, Azevedo RA, Turra KM, Rodrigues CP, Ferreira AC, Salomón MA, de Sá Junior PL, Farias CF, Figueiredo CR, Tavares LC, Barbuto JA, Jorge SD.
Ferreira AK, et al. Among authors: pasqualoto kf.
Toxicol Appl Pharmacol. 2016 Mar 15;295:56-67. doi: 10.1016/j.taap.2016.02.008. Epub 2016 Feb 10.
Toxicol Appl Pharmacol. 2016.
PMID: 26876618